chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1st dose on 26Aug2019, 2nd not received; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 55-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose on 26th August 2019).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: 1st dose on 26Aug2019, 2nd not received). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date:28-Mar-2023 The pharmacist stated that the patient has not yet received second dose, though she did receive a prescription for it from this patient's provider.   At the time of reporting, the reporter did not had the lot number or expiration date of the first dose available. The reporter gave permission for follow-up. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was reported. On an unknown date, the patient was vaccinated with an improperly stored dose of PNEUMOVAX23 for prophylaxis lot # M041394, expiration date 23-MAY-2018 (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of -2.7 degrees Celsius for 6 hours. No adverse effects were reported. There was no previous excursion. The call was due data logger. Additional information has been requested.
Pateint recieved booster dose evening of 2/11 in the right delt, IM injection. 0.25 cc Moderna. The next day around 10 AM arm was very sore and her hand and fingers were numb.  All fingers are numb, by 2/14 most of hand numbness has resolved. the right thumb and 2nd fingers are still numb on 2/15
Arm turned red/pink for a week and a half. Shortness of breath for 5 days more than normal and I am already on oxygen for COPD, 24/7.
symptoms of Guillain-Barre including progressive  numbness and weakness in the lower extremities beginning 5-6 days after vaccine administration, progressing further over the next couple of weeks.   He was hospitalized for observation but did not see a neurologist at that time.  He was later referred to our outpatient neurology clinic
11/24 Started out as sinus congestion and pain /w pain in my ear. Went to urgent care and was given a CoVid test (negative) and a physical exam. Was given amoxicillin antibiotic 10 day course for my issue. Also doctor suggested Mucinex-D and Ibuprofen for the course. Recovered well but recently went swimming and somehow caught Covid on a  past weekend trip 12/26. Had another nasal issue but found that one of my family was tested positive. Took a new test on 01/02 and currently under quarantine.
swelling; joint pain; angioedema; throat closing up; muscle pain from head to toe; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ANGIOEDEMA (angioedema), THROAT TIGHTNESS (throat closing up), JOINT SWELLING (swelling), ARTHRALGIA (joint pain) and MYALGIA (muscle pain from head to toe) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced MYALGIA (muscle pain from head to toe). On 19-Mar-2021, the patient experienced ANGIOEDEMA (angioedema) and THROAT TIGHTNESS (throat closing up). On 07-May-2021, the patient experienced JOINT SWELLING (swelling) and ARTHRALGIA (joint pain). At the time of the report, ANGIOEDEMA (angioedema), THROAT TIGHTNESS (throat closing up), JOINT SWELLING (swelling), ARTHRALGIA (joint pain) and MYALGIA (muscle pain from head to toe) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-May-2021, Histone antibody: high (Positive) histone antibodies were high. On 07-May-2021, Protein S: increased (High) spiked proteins were extremely high.         No concomitant medication information was provided.  5 weeks later, patient developed angioedema and throat closing up. Then 7 weeks later, patient developed joint pain and swelling.  No treatment medication information was provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
pt recv vax; devel fever;child's sibling devel fever while p/ recv vax;
headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Surgery (surgeries), Infection (infection in mouth) in December 2020, TMJ syndrome and Sore tongue (teeth filling sore under tongue,mouth sores and gum aching which resolved with mouth wash.). Concurrent medical conditions included Diabetes (type 2 diabetes), Carcinoid tumor (carcinoid cancer) and Colon cancer (colon cancer 11 years ago). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), METFORMIN, LINAGLIPTIN (TRAJENTA), VITAMIN D3 and VITAMIN B12 [VITAMIN B12 NOS] for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). The patient was treated with DICLOFENAC (VOLTAREN [DICLOFENAC]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. At the time of the report, HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-270115, MOD-2021-270115 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Non-significant follow-up Added.
Patient received vaccine on 11/13/19. Patient's wife called and spoke to me on the evening of 11/15/19 with concerns because the patient had developed redness and rash around injection site.
had elevated temp to 102;had 2min course of eye rolling & stiffening of arms w/shaking;no cyanosis;fine afterward;felt to be febrile sz
Information has been received from a physician concerning a 17 year old female patient who was vaccinated with a dose of GARDASIL (unknown dose by caller) at another office. The physician reported that the patient developed seizure-like activities after receiving the GARDASIL. The physician consulted with specialists at the University and they concluded that it was from the GARDASIL. He also reported that the information relayed by the patient's mother who stated that her daughter had been evaluated by a pediatric cardiologist and pediatric neurologist for syncopal episodes/seizure like episodes following the vaccination but not associated with receipt of GARDASIL. The outcome was unknown. Upon internal review "seizure-like activities" was determined to be an other important medical event. Additional information has been requested.
The patient had immunizations, 6-8 hours after he developed a fever of 103 and higher, and irritability. They lasted over 24 hours. No sign of illness before immunizations.
Information has been received from a physician concerning a 47 year old male who was vaccinated with hep b vaccine recombinant. Subsequently the pt experienced fatigue aproximately 2-3 days after receiving therapy. The pt reported that he falls asleep without warning. 10 days after therapy was administered the pt was still experiencing fatigue. On 12/04/2001 the pt was seen by a physician and there was no change in his condition. Additional info has been requested.
tiredness; headache; muscle pain; nausea; ear infection; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program Pfizer First Connect. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date in 2021 (reported as for the last weeks), patient experienced tiredness, headache, muscle pain and nausea and had to go on an antibiotic for an ear infection. Patient had Covid test, and it came back negative. Patient was scheduled for 2nd dose on Monday. The outcome of events was unknown.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Immediately after shots on both arms of Pneumonia and Shingrix I had a reaction very bad of possible Shingles on Right and left lower leg.
This spontaneous report as received from a registered nurse refers to a 24 month old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient received an adult dose of VAQTA (lot # L042039, expiration date 14-JAN-2017; dose and route and were not reported). No adverse effects were reported. Additional information has been requested.
Started on 10/16/2021 around 10 am as a very bad headache around 12 noon increased to  very bad headache, nausea, body aches extreme for 7 hrs. Then tapered off to, headache, slight nausea, body aches for 72 hrs.
Dizzy; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy) and FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizzy) and FATIGUE (Fatigue). At the time of the report, DIZZINESS (Dizzy) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant details were provided No treatment details were provided
About a month after vaccination I started losing my eye sight and having double vision. I am currently on a heart monitor because of fluttering in the heart beat.  I get very nauseated and headaches. My hearts BMP is elevated. Also starting to see platelet issues and anemia.
Noted increasing breast tenderness , first on left side and then on both sides, mostly on the lower half of my breasts. May be totally normal. May be totally unrelated to the vaccination. Just wasn't sure, so that is why I reported it.  Maybe started about 1-2 weeks after vaccination. Tenderness still remains at this time - not any worse than it was a week ago. Mostly tender to touch. They do not hurt otherwise.  My doctor stated she did not want me to get a mammogram until after seeing me first.  No redness/swelling noted. No fever.
Patient reports headache pain, right arm weakness and heaviness, abdominal pain with nausea and vomiting. These symptoms appeared the day after receiving vaccine, resolved after 2 days, then returned , now worse.  Patient is admitted to hospital due to right arm weakness.  Neurology is consulted.  Topamax 25mg  is prescribed daily.  Per neurologist, this is adverse effect of covid vaccine, shoulder injury related to vaccine administration.  She is to follow up with neurology as outpatient.  She is given a prescription for steroids at discharge.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 26-FEB-2015, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB 5 microgram/0.5ml (Thimerosal free, lot # J014855, expiration date 16-APR-2016). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree/Celsius) and the type of excursion (R/F) for each time were 48, 32, and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
polycythera; This spontaneous case was reported by a consumer and describes the occurrence of POLYCYTHAEMIA (polycythera) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced POLYCYTHAEMIA (polycythera). At the time of the report, POLYCYTHAEMIA (polycythera) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment medications were provided.
pt recv vax 20AUG96 & 19JUN97 pt devel a moderate case of shingles from mid back to nipple on rt side;30JUN97 pt recovered;
Information has been received from a pharmacist concerning a female patient who on 26-MAY-2011 was vaccinated SC with a dose of ZOSTAVAX (Merck). Following vaccination the patient developed a cellulitis. The cellulitis was described as a red, painful area at the injection site. It was unclear when the cellulitis started, but the patient called to report the redness and pain on 29-MAY-2011 and also went to emergency room (unspecified hospital) on 29-MAY-2011. The patient was treated antibiotic and pain medication. At the time of reporting, the patient had not recovered. Cellulitis was considered to be disabling by the reporter as the patient missed her work. Additional information has been requested.
sometimes feeling of loosing consciousness; pressure on heart; flutter in chest; heart fibrillation; strong tachycardia; fatigue; drop in blood pressure; restlessness; not able to concentrate; vertigo; pressure in head; Diarrhoea; This is a spontaneous report from a contactable consumer (Patient). A 48-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 16Mar2021 at 02:30 (at the age of 48 year) as dose 1, single for COVID-19 immunisation at Other. Medical history included Chronic kidney disease (one kidney let's say dysfunctional), Chronic bowel inflammation (Crohn's disease). Concomitant medication(s) included magnesium sulfate (MAGNESIUM SULFATE), acetylsalicylic acid (ACYLPYRIN), cetirizine hydrochloride (ZIRTEC). Patient had known allergies that was not to drugs but have combined crossed immunologic reactions (grass and food) which cause anaphylactic state. The covid vaccine however have not caused this reaction. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 16Mar2021, on the day of vaccination patient experienced restlessness, not able to concentrate, vertigo, fatigue in the evening and during night of the same day as vaccination day, strong tachycardia (heart fibrillation), probably radical drop in blood pressure, pressure in head, slowed perception. Heart fibrillations are so strong, that they were well noticeable (strong confused flutter in chest and feeling that patient will be faint), On 17Mar2021, the next day after vaccination continuing strong tachycardia (heart fibrillation), pressure on heart, sometimes feeling of loosing consciousness, strong vertigo, pressure in head, not able to concentrate, added diarrhoea. Third day after vaccination everything stated above, still ongoing diarrhoea, vertigo, restlessness, not able to concentrate. Tachycardia was calming down but it was still not fine, still very low blood pressure. Diarrhoea was milder, but still was present. Patient did not receive treatment for the adverse event. The outcome of Unconsciousness, fatigue and Head pressure was unknown, for Drop in blood pressure, Restlessness, Concentration impaired, Vertigo, was not recovered, for Tachycardia, Cardiac flutter, Diarrhoea, Cardiac fibrillation, Heart pressure sensation of was recovering.  Follow-up attempts are completed. No further information is expected.
Entered observation @ 1832.  @ 1836, stated that his throat was numb.  Pt was with the nurse into clinic and had pt sit on the bed in clinic.  @ 1838 Benadryl 25mg was given.  Denies SOB or Trouble Breathing.  @ 1843 pt states that s/s had been alleviated.  Insist to this nurse that he has no trouble swallowing nor breathing.  States that his throat does not feel as if it is closing up.  Just states that his throat feels numb.  @ 1850 remains to voice that he has no s/s of throat feeling numb.  Pt left observation @ 1855.  Denies this to this nurse SOB or Trouble Breathing.
Right elbow is swollen for no reason; Muscle pain/it went into right hip and it was burning and extremely painful/went to the right thigh doing the same thing; Muscle pain/it went into right hip and it was burning and extremely painful/went to the right thigh doing the same thing; Had like a Charlie horse and shooting pains down into shin; Had like a Charlie horse and shooting pains down into shin; Had really painful joint pains in both hands; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 51 year-old female patient received bnt162b2 (BNT162B2), administration date Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), administration date: Mar2021, for COVID-19 Immunization. The following information was reported: MYALGIA (non-serious), BURNING SENSATION (non-serious) all with onset 2021, outcome "recovered" (2021) and all described as "Muscle pain/it went into right hip and it was burning and extremely painful/went to the right thigh doing the same thing"; MUSCLE SPASMS (non-serious), PAIN (non-serious) all with onset 2021, outcome "recovered" (2021) and all described as "Had like a Charlie horse and shooting pains down into shin"; ARTHRALGIA (non-serious) with onset 2021, outcome "unknown", described as "Had really painful joint pains in both hands"; JOINT SWELLING (non-serious) with onset Sep2021, outcome "not recovered", described as "Right elbow is swollen for no reason".  Additional information: The reason for no lot number of Covid vaccine was because complainant does not have the product with them at the time of call. The side effects of the patient didn't last as long and no cramping. Reporter seriousness for it's almost like they are getting the same side effects and now it's attaching their joints; and they thought that was weird. Reporter called his brother to talked to him and his brother got the Moderna and got flu like symptoms and he was fine and his brother told him that withheld (his sister-in-law/patient) had the same effects and they thought that was weird, but hers didn't last long. Patient received the second dose on either the 6 or 7Apr2021. It was unknown if other vaccines given the same day or problems with vaccines in past.   This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Pt called office to describe symptoms that mimicked the flu. Nausea, aching muscles, tightness in chest, and in esophagus, also coughing. Pt stated "felt terrible".
Tiredness; Low back stiffness; pain; Severe shoulder pain; burning; cannot lift arm; Painful armpit; This is a spontaneous report from a contactable Consumer or other non-HCP (patient). A 45-year-old Adult female patient (non-pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 19Apr2021 at 08:00 AM (Lot number: Unknown) (at the age of 45-year-old) as DOSE 1, SINGLE for covid-19 immunisation.The patient was not pregnant at the time of vaccination. Medical history included Known allergies to Fragrances. The patient was not diagnosed with COVID-19, Prior to vaccination. Concomitant medications included Multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 20Apr2021, the patient experienced tiredness, low back stiffness, pain, severe shoulder pain, burning and cannot lift arm and painful armpit. No treatment was received to treat the events. The patient outcome of the events was not resolved at the time of this report.
Patient had received expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had received expired vaccine) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had received expired vaccine). On 10-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Patient had received expired vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported. It was reported that there was a failure to change the expiration date of Moderna Lot 012H21B when it was shipped. The original was kept -15 to -25 and then shipped and kept refrigerated. The lot was shipped on 06-Dec-2021 and the new expiration date should have been 05-Jan-2022 due to the refrigeration of the vaccine. The error was caught on 11-Jan-2022 when a new shipment was received and immediately stopped giving the vaccine and looked back.   This case was linked to MOD-2022-448109 (Patient Link).
Low grade fever ~100, flu-like symptoms, aches, chills, fatigue (24-48 hours post vaccination),  soreness at injection site (4 days)